i
Important informations
Instagram
Portail
Faire un don

Laboratoire

Le laboratoire de recherche en oncologie gynécologique

Le laboratoire de recherche en oncologie gynécologique (LROG) est situé à l’Institut Lady Davis de recherches médicales du Centre hospitalier universitaire général juif à Montréal, au Québec.

Notre mission est d’améliorer la vie des personnes touchées par les cancers gynécologiques. L’objectif du LROG est de déterminer les lacunes importantes dans les connaissances et d’utiliser la science fondamentale et les connaissances cliniques pour répondre aux aspects non étudiés. Nos objectifs comprennent la compréhension des mécanismes de développement des cancers gynécologiques, l’identification de leurs vulnérabilités et de leur réponse /résistance au traitement ainsi que la découverte de nouvelles thérapies moléculaires ciblées, efficaces et moins toxiques.

Les types de recherche effectués touchent aux thèmes principaux suivants :

  • Cibler les voies de réparation de l’ADN dans les cancers gynécologiques

  • Modulation épigénétique et impact sur le microenvironnement tumoral

  • Élaboration et validation de biomarqueurs prédictifs/pronostiques

  • Intégration de la biopsie liquide dans la prise en charge des cancers gynécologiques

  • Développement d’une plateforme de modèle préclinique pour la prédiction précise de l’efficacité thérapeutique des thérapies ciblées dans les essais cliniques.

La biobanque du cancer gynécologique de l’Hôpital général juif est le résultat de 20 ans de collaborations entre les patients, les cliniciens, les scientifiques et notre laboratoire. Nous avons une large biobanque (tissu, sang, ascite) d’échantillons de patients tout au long de leurs traitements.

Notre biobanque d’oncologie gynécologique est une riche source d’échantillons biologiques qui ont aidé notre équipe de recherche à faire des découvertes importantes dans le domaine des cancers gynécologiques. Cela est rendu possible grâce aux dons généreux des patients et de leurs familles ainsi qu’aux organismes de financement suivants :

  • Fonds de Recherche du Québec – Santé
  • Réseau de recherche sur le cancer
  • Société de recherche sur le cancer
  • Ovarian Cancer Research Alliance
  • Institut de recherche Terry Fox
  • Digital Health Alliance of Canada
  • Fondation Gloria Girls Gloria Shapiro
  • Fonds israélien de recherche sur le cancer
  • Fondation de l’HGJ
  • Fondation Azrieli

Meet the Team

Melica N. Brodeur 1

Recherche

Les types de recherches menées portent sur les thèmes suivants :

  • Cibler les voies de réparation de l’ADN dans les cancers gynécologiques : l’altération de l’expression des gènes de réparation est une caractéristique commune à de nombreux cancers gynécologiques. Les altérations de la réparation de l’ADN peuvent conduire à l’initiation de la tumeur et peuvent être dues à des mutations génétiques, à la régulation transcriptionnelle et aux modifications épigénétiques. Ces altérations peuvent également présenter des vulnérabilités à ces cellules cancéreuses qui peuvent être exploitées. Grâce au soutien de nos patientes-partenaires, notre équipe étudie des échantillons biologiques de patientes afin de déterminer les changements dans les protéines de réparation de l’ADN dans le développement du cancer de l’ovaire et de l’endomètre.

  • Modulation épigénétique et son impact sur le microenvironnement tumoral : le microenvironnement tumoral (TME) est devenu un domaine de recherche important. Nous comprenons maintenant qu’il existe des facteurs immunosuppresseurs qui favorisent la tumorigénèse et les interactions entre les cellules tumorales et immunitaires et les changements phénotypiques immunitaires qui influencent la réponse / résistance au traitement.

  • Développement et validation de biomarqueurs prédictifs/pronostiques : une partie de notre mission consiste à personnaliser le traitement des patients et à fournir le bon traitement, au bon moment, au bon patient. L’identification de biomarqueurs pour prédire la réponse à un traitement donné peut potentiellement éviter le sous-traitement ou le surtraitement des patients. L’utilisation des marqueurs pour les déficiences des voies de réparation de l’ADN et les tests non invasifs, tels que l’ADN tumoral circulant, constituent des nouveaux domaines d’intérêt dans notre laboratoire.

  • Intégration de la biopsie liquide dans la prise en charge des cancers gynécologiques : nous validons actuellement une méthode plus rapide et plus accessible de profilage moléculaire des tumeurs à partir de fragments d’ADN circulant dans le sang, appelés « ADN tumoral circulant » (ctDNA). Nous utilisons également le ctDNA pour détecter une maladie résiduelle minimale dans le sang, afin de mieux déterminer la durée des traitements d’entretien, tels que les inhibiteurs de PARP.

  • Développement d’une plateforme de modèles précliniques : ce thème aborde deux domaines importants : 1) comprendre la biologie fondamentale et l’étiologie de l’initiation et de la progression du cancer gynécologique, et 2) établir des modèles précliniques cliniquement pertinents pour a) améliorer la médecine de précision et b) développer une plateforme pour la prédiction précise de l’efficacité thérapeutique des thérapies ciblées dans les essais cliniques.

Les projets en cours comprennent :

  • Étude des cancers gynécologiques rares grâce au séquençage à haut débit des tumeurs, avec le soutien de l’initiative du Marathon de l’espoir Terry Fox, et mise en place d’un registre national des cancers rares par l’intermédiaire de la Société canadienne d’oncologie gynécologique et de Cancer de l’ovaire Canada.

  • Évaluation de la valeur de la chirurgie robotisée pour les patientes atteintes d’un cancer gynécologique.

  • Exploration des variations temporelles de l’expression de PD-L1 dans des échantillons de tissus de cancer du col de l’utérus stockés, afin d’évaluer comment la durée de stockage peut influencer la précision de l’évaluation immunohistochimique.

  • Identification de biomarqueurs prédictifs de la réponse à l’immunothérapie dans le cancer de l’endomètre et les cancers ovariens à cellules claires. 

  • Immunomodulation du microenvironnement tumoral ovarien afin de sensibiliser le cancer de l’ovaire à l’immunothérapie.

  • Validation de l’utilisation de l’ADNct pour le profilage moléculaire tumoral chez les patientes nouvellement diagnostiquées avec un cancer de l’ovaire.

  • Validation de la détection de l’ADNct en tant que biomarqueur permettant de déterminer la durée du traitement d’entretien, notamment par les inhibiteurs de PARP

Lorem ipsum dolor sit amet consectetur adipisicing elit. Maxime mollitia, molestiae quas vel sint commodi repudiandae consequuntur voluptatum laborum numquam blanditiis harum quisquam eius sed odit fugiat iusto fuga praesentium optio, eaque rerum! Provident similique accusantium nemo autem. Veritatis obcaecati tenetur iure eius earum ut molestias architecto voluptate aliquam nihil, eveniet aliquid culpa officia aut! Impedit sit sunt quaerat, odit, tenetur error, harum nesciunt ipsum debitis quas aliquid. Reprehenderit, quia. Quo neque error repudiandae fuga? Ipsa laudantium molestias eos sapiente officiis modi at sunt excepturi expedita sint? Sed quibusdam recusandae alias error harum maxime adipisci amet laborum. Perspiciatis minima nesciunt dolorem! Officiis iure rerum voluptates a cumque velit quibusdam sed amet tempora. Sit laborum ab, eius fugit doloribus tenetur fugiat, temporibus enim commodi iusto libero magni deleniti quod quam consequuntur! 

L'équipe

Dr. Walter Gotlieb

Walter Gotlieb, MD, PhD

Chercheur principal

After graduating with a BSc in Biology from Nebraska Wesleyan University, Koren Mann obtained a PhD in Pathology/Immunology from Boston University School of Medicine. Following that, she completed a Postdoctoral Fellowship in Oncology at McGill, where she investigated the use of arsenic as a potential chemotherapy in cancer treatment. Today, she is the Chair of the Department of Pharmacology and Therapeutics, an Associate Member of the Department of Medicine, and a Senior Investigator at the Lady Davis Institute for Medical Research.

Dr. Melica N. Brodeur

Melica Brodeur, MD, MSc, FRCSC

Chercheuse principale

After graduating with a BSc in Biology from Nebraska Wesleyan University, Koren Mann obtained a PhD in Pathology/Immunology from Boston University School of Medicine. Following that, she completed a Postdoctoral Fellowship in Oncology at McGill, where she investigated the use of arsenic as a potential chemotherapy in cancer treatment. Today, she is the Chair of the Department of Pharmacology and Therapeutics, an Associate Member of the Department of Medicine, and a Senior Investigator at the Lady Davis Institute for Medical Research.

Melica N. Brodeur 2

Susie Lau, MD, MSc, FRCSC

Cochercheuse

After graduating with a BSc in Biology from Nebraska Wesleyan University, Koren Mann obtained a PhD in Pathology/Immunology from Boston University School of Medicine. Following that, she completed a Postdoctoral Fellowship in Oncology at McGill, where she investigated the use of arsenic as a potential chemotherapy in cancer treatment. Today, she is the Chair of the Department of Pharmacology and Therapeutics, an Associate Member of the Department of Medicine, and a Senior Investigator at the Lady Davis Institute for Medical Research.

Melica N. Brodeur 2

Shannon Salvador, MD, MSc

Cochercheuse

After graduating with a BSc in Biology from Nebraska Wesleyan University, Koren Mann obtained a PhD in Pathology/Immunology from Boston University School of Medicine. Following that, she completed a Postdoctoral Fellowship in Oncology at McGill, where she investigated the use of arsenic as a potential chemotherapy in cancer treatment. Today, she is the Chair of the Department of Pharmacology and Therapeutics, an Associate Member of the Department of Medicine, and a Senior Investigator at the Lady Davis Institute for Medical Research.

Melica N. Brodeur 2

Ada Hsieh, MD

Cochercheuse

After graduating with a BSc in Biology from Nebraska Wesleyan University, Koren Mann obtained a PhD in Pathology/Immunology from Boston University School of Medicine. Following that, she completed a Postdoctoral Fellowship in Oncology at McGill, where she investigated the use of arsenic as a potential chemotherapy in cancer treatment. Today, she is the Chair of the Department of Pharmacology and Therapeutics, an Associate Member of the Department of Medicine, and a Senior Investigator at the Lady Davis Institute for Medical Research.

Associé(e) de recherche

Amber Yasmeen

Amber Yasmeen, PhD

Team Arsenic

Cynthia is the Mann lab manager. She offers support to the students with their projects, experiments and troubleshooting. She maintains a productive and positive lab environment. One of her projects involves the creation of arsenic 3 methyltransferase (As3MT) flox mice. These mice are an important tool in dissecting the role of tissue-specific As3MT in arsenic toxicity, as well as potentially identifying alternative As3MT functions.
Yorka Munoz

Yorka Munoz, PhD

Team Copper

Mitra is a research associate in the Mann Lab. After finishing her BSc in Physiology at McGill, she began her career at the Lady Davis Institute. Her project explores the role of copper, a metal commonly found in drinking water, in the progression of amyotrophic lateral sclerosis.

Assistante de recherche clinique

Melica N. Brodeur 2

Angela Tatar, MSc

Team OPE

Braeden is a PhD candidate in the Department of Pharmacology. He completed an Honours Bachelor of Science at Queen’s University with a specialization in Drug Development and Human Toxicology. His project focuses on elucidating the consequences of organophosphate esters exposure on macrophage function.

Assistante de recherche / Gérante de laboratoire

Melica N. Brodeur 2

Ayse Nazli Zengin, MSc

Team OPE

Braeden is a PhD candidate in the Department of Pharmacology. He completed an Honours Bachelor of Science at Queen’s University with a specialization in Drug Development and Human Toxicology. His project focuses on elucidating the consequences of organophosphate esters exposure on macrophage function.

Boursiers cliniques

Melica N. Brodeur 2

Aula Atamna Assaly, MD

Team Arsenic

Nivetha is a PhD candidate in the Department of Experimental Medicine. She completed her BSc in Biochemistry at Concordia University. Her project focuses on how a co-exposure to metals, such as arsenic and cadmium, affects the progression of atherosclerosis.

Yael Tal Bliman

Yael Tal Bliman, MD

Team Lymphoma

Madelyn is a PhD student in the department of Experimental Medicine. She uses mouse modelling to study Diffuse Large B Cell Lymphoma. In particular, she has found that mutations in the transcription factor STAT6 are enriched at disease relapse, and I study how this contributes to remodeling of the tumour microenvironment.

Yoav Siegler, MD

Yoav Siegler, MD

Team Lymphoma

Madelyn is a PhD student in the department of Experimental Medicine. She uses mouse modelling to study Diffuse Large B Cell Lymphoma. In particular, she has found that mutations in the transcription factor STAT6 are enriched at disease relapse, and I study how this contributes to remodeling of the tumour microenvironment.

Melica N. Brodeur 2

Bayan AlBouq, MD

Team Lymphoma

Madelyn is a PhD student in the department of Experimental Medicine. She uses mouse modelling to study Diffuse Large B Cell Lymphoma. In particular, she has found that mutations in the transcription factor STAT6 are enriched at disease relapse, and I study how this contributes to remodeling of the tumour microenvironment.

Melica N. Brodeur 2

Hamad Alharbi, MD

Team Lymphoma

Madelyn is a PhD student in the department of Experimental Medicine. She uses mouse modelling to study Diffuse Large B Cell Lymphoma. In particular, she has found that mutations in the transcription factor STAT6 are enriched at disease relapse, and I study how this contributes to remodeling of the tumour microenvironment.

Melica N. Brodeur 2

Rowa Bakadlag

Team Tungsten

Rowa is a PhD candidate in the department of Experimental Medicine. She completed her BSc in Microbiology and Immunology in Saudi Arabia, then completed two MScs in Genetics and Parasitology at McGill University. Her work investigates tungsten toxicity focusing on SLC2A2 as a transporter and the effects on mature B lymphocytes.

Boursière postdoctorale

Rowa Bakladag, PhD

Rowa Bakadlag, PhD

Team Vaping

Vincenza is an MSc. Student in the Department of Pharmacology. She completed her BSc. in Pharmacology at McGill University. Her project aims to elucidate the role of e-cigarette use on the murine cardiopulmonary system. Specifically, she is focusing on metal deposition in the lungs, and the progression of atherosclerosis due to these exposures.

Melica N. Brodeur 2

Paul-Adrien Guigue

Team Arsenic

Nazli Zengin is an MSc. student in the Department of Pharmacology. She has a background in pharmacology and environment. Her work currently focuses on elucidating how sex and diet modulate arsenic toxicity and its immunological and cardiovascular consequences.

Melica N. Brodeur 2

Andrew Little

Team Arsenic

Andrew is an MSc. student in the Department of Pharmacology who graduated from the B.Sc. program in Biochemistry at McGill in 2021. He works on a proteomics project centred around Arsenic 3-Methyltransferase and the question about whether it serves an additional function.

Melica N. Brodeur 2

Raymond Tu

Team Tungsten

Raymond is an MSc. Student in the Department of Pharmacology who completed his BSc. in Environmental Health Sciences from the UNC Chapel Hill as a as a Morehead-Cain Scholar. He received the McCall MacBain Scholarship in 2021. His project studies the mechanism of tungsten on mTORC1, a major regulator of cell growth and proliferation.

Melica N. Brodeur 2

Nikola Kukolj

Team Arsenic

Nikola is an incoming MSc Student who completed his undergraduate degree in
Microbiology and Immunology at McGill University. He is currently working on an NSERC
summer project that assesses the functional characterization of macrophages exposed to arsenic using murine bone marrow-derived macrophages.

Étudiants diplômés

Sara Daneshi

Sara Daneshi

Roni is a second-year BSc student in Chemistry at McGill. As an undergraduate student, she works on various projects across the lab, but is currently focused elucidating the correlation between nonalcoholic fatty liver disease and vaping.

Stagiaires récents

Melica N. Brodeur 2

Olivia McKeeman, MSc

Roni is a second-year BSc student in Chemistry at McGill. As an undergraduate student, she works on various projects across the lab, but is currently focused elucidating the correlation between nonalcoholic fatty liver disease and vaping.

Melica N. Brodeur 2

Peter El-Khoury, MSc

Roni is a second-year BSc student in Chemistry at McGill. As an undergraduate student, she works on various projects across the lab, but is currently focused elucidating the correlation between nonalcoholic fatty liver disease and vaping.

Melica N. Brodeur 2

Eva Kadoch, MSc

Roni is a second-year BSc student in Chemistry at McGill. As an undergraduate student, she works on various projects across the lab, but is currently focused elucidating the correlation between nonalcoholic fatty liver disease and vaping.

Publications

  • Jamieson, A., Huvila, J., Chiu, D., Thompson, E. F., Scott, S., Salvador, S., Vicus, D., Helpman, L., Gotlieb, W., Kean, S., Samouelian, V., Köbel, M., Kinloch, M., Parra-Harran, C., Offman, S., Grondin, K., Irving, J., Lum, A., Senz, J., Leung, S., … McAlpine, J. N. (2023). Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 36(4), 100085. https://doi.org/10.1016/j.modpat.2022.100085
  • Zhu, X., Fu, Z., Aceto, G., St-Germain, J., Liu, K., Arabzadeh, A., Qi, Y., Xue, Y., Witkowski, L., Graulich, E., Steinberger, J., Misirlioglu, S., Bassani, N., Sansal, R., Yasmeen, A., Morin, G., Guo, J., Monast, A., Pilon, V., Valachová, A., … Huang, S. (2025). SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer. Cancer research, 85(16), 2997–3014. https://doi.org/10.1158/0008-5472.CAN-24-3990
  • Levin, G., & Gotlieb, W. H. (2024). Interleukine-10 in ovarian cancer. Chinese clinical oncology, 13(4), 48. https://doi.org/10.21037/cco-23-135
  • Levin, G., & Gotlieb, W. H. (2024). Fertility-preserving treatments for endometrial intraepithelial neoplasia: the known unknowns. Journal of the National Cancer Institute, 116(5), 633–634. https://doi.org/10.1093/jnci/djae057
  • Leitao, M. M., Jr, Bixel, K. L., Chase, D. M., Quick, A., McCormick, C., Black, D., Lim, P. C., Eskander, R. N., Gotlieb, W. H., LoCoco, S., Martino, M. A., Walker, J. L., Copeland, L. J., Monk, B. J., & Randall, L. M. (2025). ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 35(7), 101760. https://doi.org/10.1016/j.ijgc.2025.101760
  • Spénard, E., Jacobson, M., Rouzbahman, M., Hoang, L., Grondin, K., Koebel, M., Kwon, J., Stewart, K., Plante, M., Teo-Fortin, L. A., Vicus, D., Cameron, A., Power, P., Hsieh, A., Feigenberg, T., Eiriksson, L., Provencher, D., Gotlieb, W., Kieser, K., Pin, S., … Bernardini, M. Q. (2025). Canadian Management of Serous Tubal Intraepithelial Carcinoma. Obstetrics and gynecology, 146(3), 302–313. https://doi.org/10.1097/AOG.0000000000006016
  • Gotlieb, W. H., & Tzur, Y. (2024). Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer. Gynecology and pelvic medicine, 7, 8. https://doi.org/10.21037/gpm-23-35
  • Schnitman, G., Wang, T., Kundu, S., Turkdogan, S., Gotlieb, R., How, J., & Gotlieb, W. (2022). The role of digital patient education in maternal health: A systematic review. Patient education and counseling, 105(3), 586–593. https://doi.org/10.1016/j.pec.2021.06.019
  • Levin, G., Capella, M. P., Meyer, R., Brezinov, Y., & Gotlieb, W. H. (2024). Gynecologic perivascular epithelioid cell tumors (PEComas): a review of recent evidence. Archives of gynecology and obstetrics, 309(6), 2381–2386. https://doi.org/10.1007/s00404-024-07510-5
  • Le Page, C., Amuzu, S., Rahimi, K., Gotlieb, W., Ragoussis, J., & Tonin, P. N. (2021). Lessons learned from understanding chemotherapy resistance in epithelial tubo-ovarian carcinoma from BRCA1and BRCA2mutation carriers. Seminars in cancer biology, 77, 110–126. https://doi.org/10.1016/j.semcancer.2020.08.005
  • Nyangoh Timoh, K., Galuret, S., Hébert, T., Azaïs, H., Barahona, M., Becker, S., Bolze, P. A., Boisramé, T., Borghese, B., Carbonnel, M., Cela, V., Chauleur, C., Chalhoub, T., Cheung, T. H., Closon, F., Crochet, P., Dabi, Y., De Landsheere, L., Faller, E., Fanfani, F., … Jannin, P. (2026). International expert consensus-driven surgical process model for robot-assisted hysterectomy: Delphi study results. Surgical endoscopy, 40(1), 541–552. https://doi.org/10.1007/s00464-025-12339-3
  • Matanes, E., Volodarsky-Perel, A., Eisenberg, N., Rottenstreich, M., Yasmeen, A., Mitric, C., Lau, S., Salvador, S., Gotlieb, W. H., & Kogan, L. (2021). Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis. Journal of minimally invasive gynecology, 28(5), 947–956. https://doi.org/10.1016/j.jmig.2020.11.023
  • Levin, G., Gotlieb, W. H., Zand, B., Zaid, T., Meyer, R., Yates, E., & Ramirez, P. T. (2024). Robotic Surgery in Gynecologic Oncology-A Bibliometric Study. Journal of minimally invasive gynecology, 31(10), 882–889. https://doi.org/10.1016/j.jmig.2024.07.002
  • Levin, G., & Gotlieb, W. H. (2024). Minimally invasive cytoreduction for advanced-stage ovarian cancer-a narrative review. Gynecology and pelvic medicine, 7, 32. https://doi.org/10.21037/gpm-24-25
  • Levin, G., Lau, S., Salvador, S., Brodeur, M., Meyer, R., & Gotlieb, W. (2026). Adjuvant radiotherapy for early-stage endometrial cancer based on randomized controlled trials: a narrative review. Minerva obstetrics and gynecology, 78(2), 142–147. https://doi.org/10.23736/S2724-606X.25.05723-9
  • Mitric, C., Lakabi, R., Kligun, G., Matanes, E., Lau, S., Gotlieb, W. H., & Salvador, S. (2023). Endocervical sampling using brush versus curette: a single centre experience and literature review. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 43(1), 2162866. https://doi.org/10.1080/01443615.2022.2162866
  • Gomolin, A., Gotlieb, W., Lau, S., Salvador, S., Racovitan, F., & Abitbol, J. (2022). Mandate to evaluate robotic surgery implementation: a 12-year retrospective analysis of impact and future implications. Journal of robotic surgery, 16(4), 783–788. https://doi.org/10.1007/s11701-021-01327-z
  • McCuaig, J. M., Stockley, T. L., Shaw, P., Fung-Kee-Fung, M., Altman, A. D., Bentley, J., Bernardini, M. Q., Cormier, B., Hirte, H., Kieser, K., MacMillan, A., Meschino, W. S., Panabaker, K., Perrier, R., Provencher, D., Schrader, K. A., Serfas, K., Tomiak, E., Wong, N., Young, S. S., … BRCA TtoT Community of Practice (2018). Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap. Journal of medical genetics, 55(9), 571–577. https://doi.org/10.1136/jmedgenet-2018-105472
  • Piedimonte, S., Frank, C., Laprise, C., Quaiattini, A., & Gotlieb, W. H. (2020). Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review. Obstetrics and gynecology, 135(3), 498–508. https://doi.org/10.1097/AOG.0000000000003702
  • Knigin, D., Brezinov, Y., Salvador, S., Lau, S., & Gotlieb, W. H. (2024). Surgery Advances in Gynecologic Tumors: The Evolution and Outcomes of Robotic Surgery for Gynecologic Cancers in a Tertiary Center. Current oncology (Toronto, Ont.), 31(5), 2400–2409. https://doi.org/10.3390/curroncol31050179
  • Grundy, A., Sandhu, S., Arseneau, J., Gilbert, L., Gotlieb, W. H., Aronson, K. J., & Koushik, A. (2022). Lifetime caffeine intake and the risk of epithelial ovarian cancer. Cancer epidemiology, 76, 102058. https://doi.org/10.1016/j.canep.2021.102058
  • Thompson, E. F., Huvila, J., Jamieson, A., Leung, S., Lum, A., Offman, S., Lytwyn, A., Sur, M. L., Hoang, L., Irving, J., van der Westhuizen, N., Morin, C., Bicamumpaka, C., Azordegan, N., Gougeon, F., Ennour-Idrissi, K., Senz, J., McConechy, M. K., Aguirre-Hernandez, R., Lui, V., … Society of Gynecologic Oncologists of Canada (CoP, Translational Research) (2022). Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 35(12), 1974–1982. https://doi.org/10.1038/s41379-022-01165-w
  • How, J. A., O’Farrell, P., Amajoud, Z., Lau, S., Salvador, S., How, E., & Gotlieb, W. H. (2018). Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Minerva ginecologica, 70(2), 194–214. https://doi.org/10.23736/S0026-4784.17.04179-X
  • Cyr, M. P., Camden, C., Dumoulin, C., Dostie, R., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2023). Gynecological Cancer Survivors’ Experiences of Dyspareunia and Factors Influencing Care-Seeking Behavior: A Qualitative Study. Archives of sexual behavior, 52(6), 2669–2681. https://doi.org/10.1007/s10508-023-02589-4
  • L’Espérance, K., Grundy, A., Abrahamowicz, M., Arseneau, J., Gilbert, L., Gotlieb, W. H., Provencher, D., & Koushik, A. (2023). Alcohol intake and the risk of epithelial ovarian cancer. Cancer causes & control : CCC, 34(6), 533–541. https://doi.org/10.1007/s10552-023-01681-3
  • Scalia, P., Levin, G., Bar Noy, T., Salvador, S., Nourmoussavi Brodeur, M., Gotlieb, W., & Lau, S. K. (2025). Conversion Rate for Robotic-Assisted Gynecologic Cancer Surgery. Obstetrics and gynecology, 146(4), 563–565. https://doi.org/10.1097/AOG.0000000000006017
  • Matanes, E., Amajoud, Z., Salvador, S., Lau, S., & Gotlieb, W. (2022). Four protective maneuvers in minimal invasive surgery of endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 32(7), 953–954. https://doi.org/10.1136/ijgc-2021-003324
  • Levin, G., Siedhoff, M., Wright, K. N., Truong, M. D., Hamilton, K., Brezinov, Y., Gotlieb, W., & Meyer, R. (2023). Robotic surgery in obstetrics and gynecology: a bibliometric study. Journal of robotic surgery, 17(5), 2387–2397. https://doi.org/10.1007/s11701-023-01672-1
  • Levin, G., Brezinov, Y., Tzur, Y., Bar-Noy, T., Brodeur, M. N., Salvador, S., Lau, S., & Gotlieb, W. (2024). Association between BMI and oncologic outcomes in epithelial ovarian cancer: a predictors-matched case-control study. Archives of gynecology and obstetrics, 310(1), 587–593. https://doi.org/10.1007/s00404-024-07537-8
  • Le Page, C., Rahimi, K., Rodrigues, M., Heinzelmann-Schwarz, V., Recio, N., Tommasi, S., Bataillon, G., Portelance, L., Golmard, L., Meunier, L., Tonin, P. N., Gotlieb, W., Yasmeen, A., Ray-Coquard, I., Labidi-Galy, S. I., Provencher, D., & Mes-Masson, A. M. (2020). Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis. Gynecologic oncology, 156(2), 377–386. https://doi.org/10.1016/j.ygyno.2019.11.019
  • Levin, G., Matanes, E., Brezinov, Y., Ferenczy, A., Pelmus, M., Brodeur, M. N., Salvador, S., Lau, S., & Gotlieb, W. H. (2024). Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 50(3), 108006. https://doi.org/10.1016/j.ejso.2024.108006
  • Matanes, E., Cantor, T., AlShehri, E., Salvador, S., Lau, S., & Gotlieb, W. (2022). Surgical technique for sentinel lymph node sampling in endometrial cancer using the articulated HOOK monopolar instrument. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 32(7), 951–952. https://doi.org/10.1136/ijgc-2021-002840
  • Holloway, R. W., Abu-Rustum, N. R., Backes, F. J., Boggess, J. F., Gotlieb, W. H., Jeffrey Lowery, W., Rossi, E. C., Tanner, E. J., & Wolsky, R. J. (2017). Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecologic oncology, 146(2), 405–415. https://doi.org/10.1016/j.ygyno.2017.05.027
  • Xue, Y., Morris, J. L., Yang, K., Fu, Z., Zhu, X., Johnson, F., Meehan, B., Witkowski, L., Yasmeen, A., Golenar, T., Coatham, M., Morin, G., Monast, A., Pilon, V., Fiset, P. O., Jung, S., Gonzalez, A. V., Camilleri-Broet, S., Fu, L., Postovit, L. M., … Huang, S. (2021). SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+flux to mitochondria. Nature communications, 12(1), 5404. https://doi.org/10.1038/s41467-021-25260-9
  • Levin, G., Brezinov, Y., Meyer, R., Lau, S., Salvador, S., & Gotlieb, W. H. (2024). The value of multicenter collaboration in Gynecologic Oncology research. Minerva obstetrics and gynecology, 76(6), 558–563. https://doi.org/10.23736/S2724-606X.23.05451-9
  • Matanes, E., Amajoud, Z., Kogan, L., Mitric, C., Ismail, S., Raban, O., Knigin, D., Levin, G., Bahoric, B., Ferenczy, A., Pelmus, M., Lecavalier-Barsoum, M., Lau, S., Salvador, S., & Gotlieb, W. H. (2023). Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?. Gynecologic oncology, 168, 107–113. https://doi.org/10.1016/j.ygyno.2022.10.023
  • Xue, Y., Morris, J. L., Yang, K., Fu, Z., Zhu, X., Johnson, F., Meehan, B., Witkowski, L., Yasmeen, A., Golenar, T., Coatham, M., Morin, G., Monast, A., Pilon, V., Fiset, P. O., Jung, S., Gonzalez, A. V., Camilleri-Broet, S., Fu, L., Postovit, L. M., … Huang, S. (2023). Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+flux to mitochondria. Nature communications, 14(1), 1552. https://doi.org/10.1038/s41467-023-37144-1
  • Ahmed, S., Gotlieb, W. H., Erez, G., & Loiselle, C. G. (2022). Perceptions of BELONG as a supportive e-platform used by women with gynecologic cancers. Psycho-oncology, 31(1), 152–156. https://doi.org/10.1002/pon.5785
  • Kogan, L., Matanes, E., Wissing, M., Mitric, C., How, J., Amajoud, Z., Abitbol, J., Yasmeen, A., López-Ozuna, V., Eisenberg, N., Lau, S., Salvador, S., & Gotlieb, W. H. (2020). The added value of sentinel node mapping in endometrial cancer. Gynecologic oncology, 158(1), 84–91. https://doi.org/10.1016/j.ygyno.2020.04.687
  • Marchocki, Z., Cusimano, M. C., Clarfield, L., Kim, S. R., Fazelzad, R., Espin-Garcia, O., Bouchard-Fortier, G., Rossi, E. C., Stewart, K. I., Soliman, P. T., How, J. A., Gotlieb, W. H., Holloway, R. W., Ianieri, M. M., Cabrera, S., Lim, Y. K., & Ferguson, S. E. (2021). Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. American journal of obstetrics and gynecology, 225(4), 367.e1–367.e39. https://doi.org/10.1016/j.ajog.2021.05.034
  • Levin, G., Brezinov, Y., Tzur, Y., Meyer, R., & Gotlieb, W. (2024). Enhancing patient care in low-volume practice settings: the crucial role of overseas sub-specialty training. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 34(12), 1980–1981. https://doi.org/10.1136/ijgc-2024-005936
  • Leung, L., Grundy, A., Siemiatycki, J., Arseneau, J., Gilbert, L., Gotlieb, W. H., Provencher, D. M., Aronson, K. J., & Koushik, A. (2019). Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer Risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 28(5), 987–995. https://doi.org/10.1158/1055-9965.EPI-18-1112
  • How, J., Boldeanu, I., Lau, S., Salvador, S., How, E., Gotlieb, R., Abitbol, J., Halder, A., Amajoud, Z., Probst, S., Brin, S., & Gotlieb, W. (2017). Unexpected locations of sentinel lymph nodes in endometrial cancer. Gynecologic oncology, 147(1), 18–23. https://doi.org/10.1016/j.ygyno.2017.07.125
  • Abitbol, J., Kucukyazici, B., Brin, S., Lau, S., Salvador, S., Ramanakumar, A. V., Kessous, R., Kogan, L., Fletcher, J. D., Pare-Miron, V., Liu, G., & Gotlieb, W. H. (2023). Impact of robotic surgery on patient flow and resource use intensity in ovarian cancer. Journal of robotic surgery, 17(2), 537–547. https://doi.org/10.1007/s11701-022-01447-0
  • Piedimonte, S., Feigenberg, T., Drysdale, E., Kwon, J., Gotlieb, W. H., Cormier, B., Plante, M., Lau, S., Helpman, L., Renaud, M. C., May, T., & Vicus, D. (2022). Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learning. Journal of surgical oncology, 126(6), 1096–1103. https://doi.org/10.1002/jso.27008
  • Hoskins, P. J., & Gotlieb, W. H. (2017). Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature. CA: a cancer journal for clinicians, 67(6), 493–506. https://doi.org/10.3322/caac.21408
  • El-Zein, M., Cheishvili, D., Gotlieb, W., Gilbert, L., Hemmings, R., Behr, M. A., Szyf, M., Franco, E. L., & MARKER study group (2020). Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia. International journal of cancer, 147(5), 1264–1274. https://doi.org/10.1002/ijc.32880
  • Jamieson, A., Huvila, J., Thompson, E. F., Leung, S., Chiu, D., Lum, A., McConechy, M., Grondin, K., Aguirre-Hernandez, R., Salvador, S., Kean, S., Samouelian, V., Gougeon, F., Azordegan, N., Lytwyn, A., Parra-Herran, C., Offman, S., Gotlieb, W., Irving, J., Kinloch, M., … McAlpine, J. N. (2022). Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification. Gynecologic oncology, 165(2), 201–214. https://doi.org/10.1016/j.ygyno.2022.02.001
  • Matanes, E., & Gotlieb, W. H. (2021). Pathophysiological and anatomical basis of lymphatic transit of cancer cells and role of the lymphatic system: a review of published literature. Chinese clinical oncology, 10(2), 14. https://doi.org/10.21037/cco-20-205
  • Kessous, R., Matanes, E., Laskov, I., Wainstock, T., Abitbol, J., Yasmeen, A., Salvador, S., Lau, S., & Gotlieb, W. H. (2021). Carboplatin plus paclitaxel weekly dose-dense chemotherapy for high-grade ovarian cancer: A re-evaluation. Acta obstetricia et gynecologica Scandinavica, 100(3), 453–458. https://doi.org/10.1111/aogs.14023
  • Elkholi, I. E., Di Iorio, M., Fahiminiya, S., Arcand, S. L., Han, H., Nogué, C., Behl, S., Hamel, N., Giroux, S., de Ladurantaye, M., Aleynikova, O., Gotlieb, W. H., Côté, J. F., Rousseau, F., Tonin, P. N., Provencher, D., MesMasson, A. M., Akbari, M. R., Rivera, B., & Foulkes, W. D. (2021). Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. Scientific reports, 11(1), 2409. https://doi.org/10.1038/s41598-021-81106-w
  • Grundy, A., Ho, V., Abrahamowicz, M., Parent, M. É., Siemiatycki, J., Arseneau, J., Gilbert, L., Gotlieb, W. H., Provencher, D. M., & Koushik, A. (2020). Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control study. International journal of cancer, 146(7), 1800–1809. https://doi.org/10.1002/ijc.32513
  • Matanes, E., Eisenberg, N., Mitric, C., Yasmeen, A., Ismail, S., Raban, O., Cantor, T., Knigin, D., Lau, S., Salvador, S., Gotlieb, W., & Kogan, L. (2022). Surgical and oncological outcomes of sentinel lymph node sampling in elderly patients with intermediate to high-risk endometrial carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 32(7), 875–881. https://doi.org/10.1136/ijgc-2022-003431
  • Levin, G., Brezinov, Y., Brodeur, M. N., Salvador, S., Lau, S., & Gotlieb, W. (2024). Gynecologic oncology robot-assisted surgery in octogenarians: Impact of age on hospital stay. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 167(2), 784–788. https://doi.org/10.1002/ijgo.15688
  • Kessous, R., Laskov, I., Abitbol, J., Bitharas, J., Yasmeen, A., Salvador, S., Lau, S., & Gotlieb, W. H. (2017). Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer. Gynecologic oncology, 144(3), 474–479. https://doi.org/10.1016/j.ygyno.2016.12.017
  • Laskov, I., Michaan, N., Zeng, X., Salvador, S., Lau, S., Gilbert, L., Gotlieb, W. H., & Kessous, R. (2024). The Impact of Intrauterine Manipulators on Outcome and Recurrence Patterns of Endometrial Cancer Patients Undergoing Minimally Invasive Surgery. Journal of women’s health (2002), 33(3), 355–363. https://doi.org/10.1089/jwh.2023.0246
  • Guigue, P. A., Brezinov, Y., Yasmeen, A., Mbarik, M., Salvador, S., Lau, S., Gotlieb, W. H., & Brodeur, M. N. (2024). Ascites and Serum Interleukin-10 Levels as a Prognostic Tool for Ovarian Cancer Outcomes. Cancers, 16(16), 2840. https://doi.org/10.3390/cancers16162840
  • Kadoch, E., Brezinov, Y., Levin, G., Racovitan, F., Lau, S., Salvador, S., & Gotlieb, W. H. (2024). The impact of body mass index on robotic surgery outcomes in endometrial cancer. Gynecologic oncology, 185, 51–57. https://doi.org/10.1016/j.ygyno.2024.01.051
  • Xue, Y., Meehan, B., Macdonald, E., Venneti, S., Wang, X. Q. D., Witkowski, L., Jelinic, P., Kong, T., Martinez, D., Morin, G., Firlit, M., Abedini, A., Johnson, R. M., Cencic, R., Patibandla, J., Chen, H., Papadakis, A. I., Auguste, A., de Rink, I., Kerkhoven, R. M., … Huang, S. (2019). CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature communications, 10(1), 558. https://doi.org/10.1038/s41467-018-06958-9
  • Touhami, O., De Guerke, L., Teo Fortin, L. A., Foo, J., Provencher, D., Samouelian, V., Cormier, B., Lau, S., Salvador, S., Gotlieb, W., Gilbert, L., Laframboise, S., Altman, A. D., Ghatage, P., Brar, H., Kwon, J., Le, T., Sebastianelli, A., Fokom Domgue, J., & Plante, M. (2024). Global distribution and career outcomes of international fellows trained in Canadian gynecologic oncology programs. Gynecologic oncology reports, 56, 101512. https://doi.org/10.1016/j.gore.2024.101512
  • Abitbol, J., Gotlieb, W., Zeng, Z., Ramanakumar, A., Kessous, R., Kogan, L., Pare-Miron, V., Rombaldi, M., Salvador, S., Kucukyazici, B., Brin, S., How, J., & Lau, S. (2019). Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 29(9), 1341–1347. https://doi.org/10.1136/ijgc-2019-000413
  • Wissing, M., Mitric, C., Amajoud, Z., Abitbol, J., Yasmeen, A., López-Ozuna, V., How, J., Kessous, R., Eisenberg, N., Lau, S., Salvador, S., Gotlieb, W. H., & Kogan, L. (2019). Risk factors for lymph nodes involvement in obese women with endometrial carcinomas. Gynecologic oncology, 155(1), 27–33. https://doi.org/10.1016/j.ygyno.2019.07.016
  • Cyr, M. P., Dostie, R., Camden, C., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2022). Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: Results from a one-year follow-up mixed-method study. PloS one, 17(1), e0262844. https://doi.org/10.1371/journal.pone.0262844
  • Octeau, D., Kessous, R., Klein, K., Kogan, L., Pelmus, M., Ferenczy, A., Greenwood, C. M. T., Van Kempen, L. C., Salvador, S., Lau, S., Tonin, P. N., Yasmeen, A., & Gotlieb, W. H. (2019). Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy. Molecular cancer research : MCR, 17(12), 2422–2431. https://doi.org/10.1158/1541-7786.MCR-19-0398
  • Galan, A., Papaluca, A., Nejatie, A., Matanes, E., Brahimi, F., Tong, W., Hachim, I. Y., Yasmeen, A., Carmona, E., Klein, K. O., Billes, S., Dawod, A. E., Gawande, P., Jeter, A. M., Mes-Masson, A. M., Greenwood, C. M. T., Gotlieb, W. H., & Saragovi, H. U. (2023). GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer. Frontiers in oncology, 13, 1134763. https://doi.org/10.3389/fonc.2023.1134763
  • Laskov, I., Kessous, R., Abitbol, J., Kogan, L., Badeghiesh, A., Tagalakis, V., Cohen, S., Salvador, S., Lau, S., Gotlieb, W. H., & SOGC Communities of Practice (2018). Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 40(12), 1571–1579. https://doi.org/10.1016/j.jogc.2018.04.003
  • How, J., Gauthier, C., Abitbol, J., Lau, S., Salvador, S., Gotlieb, R., Pelmus, M., Ferenczy, A., Probst, S., Brin, S., Fatnassi, A., & Gotlieb, W. (2017). Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer. Gynecologic oncology, 144(3), 503–509. https://doi.org/10.1016/j.ygyno.2017.01.013
  • Knigin, D., Nadeau, P., Matanes, E., Salvador, S., Gotlieb, W. H., & Lau, S. (2025). The benefit of sentinel lymph node evaluation in pre-operative grade 1 endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 35(12), 101939. https://doi.org/10.1016/j.ijgc.2025.101939
  • Xue, Y., Zhu, X., Meehan, B., Venneti, S., Martinez, D., Morin, G., Maïga, R. I., Chen, H., Papadakis, A. I., Johnson, R. M., O’Sullivan, M. J., Erdreich-Epstein, A., Gotlieb, W. H., Park, M., Judkins, A. R., Pelletier, J., Foulkes, W. D., Rak, J., & Huang, S. (2020). SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of pathology, 252(1), 77–87. https://doi.org/10.1002/path.5493
  • Kogan, L., Laskov, I., Amajoud, Z., Abitbol, J., Yasmeen, A., Octeau, D., Fatnassi, A., Kessous, R., Eisenberg, N., Lau, S., Gotlieb, W. H., & Salvador, S. (2017). Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer. Gynecologic oncology, 147(1), 30–35. https://doi.org/10.1016/j.ygyno.2017.07.134
  • Jamieson, A., Huvila, J., Chiu, D., Thompson, E. F., Scott, S., Salvador, S., Vicus, D., Helpman, L., Gotlieb, W., Kean, S., Samouelian, V., Köbel, M., Kinloch, M., Parra-Herran, C., Offman, S., Grondin, K., Irving, J., Lum, A., Senz, J., Leung, S., … McAlpine, J. N. (2023). Corrigendum to « Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death »: [Modern Pathology 36 (2023) 100085]. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 36(6), 100212. https://doi.org/10.1016/j.modpat.2023.100212
  • Levin, G., Matanes, E., Salvador, S., Lau, S., & Gotlieb, W. (2024). Time interval from biopsy of endometrial atypical hyperplasia to surgery and risk for concurrent endometrial carcinoma – A retrospective study. BJOG : an international journal of obstetrics and gynaecology, 131(9), 1320–1321. https://doi.org/10.1111/1471-0528.17763
  • Baloch, T., López-Ozuna, V. M., Wang, Q., Matanis, E., Kessous, R., Kogan, L., Yasmeen, A., & Gotlieb, W. H. (2019). Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1. BMC cancer, 19(1), 44. https://doi.org/10.1186/s12885-018-5250-4
  • El-Zein, M., Ali, R., Farah, E., Botting-Provost, S., Franco, E. L., & Survey Study Group (2023). Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals. eLife, 12, e83764. https://doi.org/10.7554/eLife.83764
  • Sherill-Rofe, D., Raban, O., Findlay, S., Rahat, D., Unterman, I., Samiei, A., Yasmeen, A., Kaiser, Z., Kuasne, H., Park, M., Foulkes, W. D., Bloch, I., Zick, A., Gotlieb, W. H., Tabach, Y., & Orthwein, A. (2022). Multi-omics data integration analysis identifies the spliceosome as a key regulator of DNA double-strand break repair. NAR cancer, 4(2), zcac013. https://doi.org/10.1093/narcan/zcac013
  • López-Ozuna, V. M., Kogan, L., Hachim, M. Y., Matanes, E., Hachim, I. Y., Mitric, C., Kiow, L. L. C., Lau, S., Salvador, S., Yasmeen, A., & Gotlieb, W. H. (2021). Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer. Frontiers in oncology, 11, 695404. https://doi.org/10.3389/fonc.2021.695404
  • Meyer, R., Ezike, O., Ciesielski, K., Ngo, N., Taing, S., Gotlieb, W., & Levin, G. (2025). Trends and outcomes of minimally invasive hysterectomy among older women. Maturitas, 196, 108244. https://doi.org/10.1016/j.maturitas.2025.108244
  • Le Page, C., Rahimi, K., Köbel, M., Tonin, P. N., Meunier, L., Portelance, L., Bernard, M., Nelson, B. H., Bernardini, M. Q., Bartlett, J. M. S., Bachvarov, D., Gotlieb, W. H., Gilks, B., McAlpine, J. N., Nachtigal, M. W., Piché, A., Watson, P. H., Vanderhyden, B., Huntsman, D. G., Provencher, D. M., … Mes-Masson, A. M. (2018). Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers. BMC cancer, 18(1), 347. https://doi.org/10.1186/s12885-018-4242-8
  • Cyr, M. P., Dostie, R., Camden, C., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2023). Acceptability of multimodal pelvic floor physical therapy to treat dyspareunia after gynecological malignancies: a qualitative study of women’s views and experiences. International urogynecology journal, 34(5), 1061–1073. https://doi.org/10.1007/s00192-022-05304-4
  • Leung, A., Abitbol, J., Ramana-Kumar, A. V., Fadlallah, B., Kessous, R., Cohen, S., Lau, S., Salvador, S., & Gotlieb, W. H. (2017). Outside the operating room: How a robotics program changed resource utilization on the inpatient Ward. Gynecologic oncology, 145(1), 102–107. https://doi.org/10.1016/j.ygyno.2017.01.034
  • Kessous, R., Wissing, M. D., Laskov, I., Abitbol, J., Bitharas, J., Agnihotram, V. R., Yasmeen, A., Salvador, S., Lau, S., & Gotlieb, W. H. (2021). Multiple lines of chemotherapy for patients with high-grade ovarian cancer: Predictors for response and effect on survival. International journal of cancer, 148(9), 2304–2312. https://doi.org/10.1002/ijc.33395
  • Malagón, T., Mayrand, M. H., Ogilvie, G., Gotlieb, W. H., Blake, J., Bouchard, C., Franco, E. L., & Kulasingam, S. (2020). Modeling the Balance of Benefits and Harms of Cervical Cancer Screening with Cytology and Human Papillomavirus Testing. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 29(7), 1436–1446. https://doi.org/10.1158/1055-9965.EPI-20-0190
  • Levin, G., Gotlieb, W., Ramirez, P., Meyer, R., & Brezinov, Y. (2025). ChatGPT in a gynaecologic oncology multidisciplinary team tumour board: A feasibility study. BJOG : an international journal of obstetrics and gynaecology, 132(1), 99–101. https://doi.org/10.1111/1471-0528.17929
  • Matanes, E., Eisenberg, N., Lau, S., Salvador, S., Ferenczy, A., Pelmus, M., Gotlieb, W. H., & Kogan, L. (2021). Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes. Gynecologic oncology, 162(2), 256–261. https://doi.org/10.1016/j.ygyno.2021.05.040
  • Mitric, C., Matanes, E., Wissing, M., Amajoud, Z., Abitbol, J., Yasmeen, A., López-Ozuna, V., Eisenberg, N., Laskov, I., Lau, S., Salvador, S., Gotlieb, W. H., & Kogan, L. (2020). The impact of wait times on oncological outcome in high-risk patients with endometrial cancer. Journal of surgical oncology, 122(2), 306–314. https://doi.org/10.1002/jso.25929
  • Koushik, A., Grundy, A., Abrahamowicz, M., Arseneau, J., Gilbert, L., Gotlieb, W. H., Lacaille, J., Mes-Masson, A. M., Parent, M. É., Provencher, D. M., Richardson, L., & Siemiatycki, J. (2017). Hormonal and reproductive factors and the risk of ovarian cancer. Cancer causes & control : CCC, 28(5), 393–403. https://doi.org/10.1007/s10552-016-0848-9
  • Turkdogan, S., Schnitman, G., Wang, T., Gotlieb, R., How, J., & Gotlieb, W. H. (2021). Development of a Digital Patient Education Tool for Patients With Cancer During the COVID-19 Pandemic. JMIR cancer, 7(2), e23637. https://doi.org/10.2196/23637
  • Tzur, Y., Magri, A., Meyer, R., Brodeur, M. N., Salvador, S., Lau, S., Gotlieb, W., & Levin, G. (2025). Association between body mass index, obesity, and vulvar cancer recurrence. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 170(1), 268–273. https://doi.org/10.1002/ijgo.16182
  • Abitbol, J., Cohn, R., Hunter, S., Rombaldi, M., Cohen, E., Kessous, R., Large, N., Reiss, A., Lau, S., Salvador, S., & Gotlieb, W. H. (2017). Minimizing pain medication use and its associated costs following robotic surgery. Gynecologic oncology, 144(1), 187–192. https://doi.org/10.1016/j.ygyno.2016.11.014
  • Cyr, M. P., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2022). Changes in pelvic floor morphometry and muscle function after multimodal physiotherapy for gynaecological cancer survivors suffering from dyspareunia: a prospective interventional study. Physiotherapy, 114, 54–62. https://doi.org/10.1016/j.physio.2021.09.003
  • El-Zein, M., Bouten, S., Louvanto, K., Gilbert, L., Gotlieb, W. H., Hemmings, R., Behr, M. A., Franco, E. L., & CASSIS Study Group* (2019). Predictive Value of HPV Testing in Self-collected and Clinician-Collected Samples Compared with Cytology in Detecting High-grade Cervical Lesions. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 28(7), 1134–1140. https://doi.org/10.1158/1055-9965.EPI-18-1338
  • Kessous, R., How, J., Abitbol, J., Puzhakkal, S., Kogan, L., Yasmeen, A., Salvador, S., Gotlieb, W. H., & Lau, S. (2019). Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 29(7), 1121–1125. https://doi.org/10.1136/ijgc-2019-000387
  • El-Zein, M., Gotlieb, W., Gilbert, L., Hemmings, R., Behr, M. A., Franco, E. L., & STAIN-IT Study Group (2021). Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study. International journal of cancer, 148(2), 492–501. https://doi.org/10.1002/ijc.33250
  • Cyr, M. P., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., & Morin, M. (2021). Characterizing Pelvic Floor Muscle Function and Morphometry in Survivors of Gynecological Cancer Who Have Dyspareunia: A Comparative Cross-Sectional Study. Physical therapy, 101(4), pzab042. https://doi.org/10.1093/ptj/pzab042
  • Shallwani, S. M., Towers, A., Newman, A., Salvador, S., Yung, A., Gilbert, L., Gotlieb, W. H., Zeng, X., & Thomas, D. (2021). Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema. Current oncology (Toronto, Ont.), 28(1), 455–470. https://doi.org/10.3390/curroncol28010048
  • Matanes, E., Abitbol, J., Kessous, R., Kogan, L., Octeau, D., Lau, S., Salvador, S., & Gotlieb, W. H. (2019). Oncologic and Surgical Outcomes of Robotic Versus Open Radical Hysterectomy for Cervical Cancer. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 41(4), 450–458. https://doi.org/10.1016/j.jogc.2018.09.013
  • Cyr, M. P., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2021). A Prospective Single-Arm Study Evaluating the Effects of a Multimodal Physical Therapy Intervention on Psychosexual Outcomes in Women With Dyspareunia After Gynecologic Cancer. The journal of sexual medicine, 18(5), 946–954. https://doi.org/10.1016/j.jsxm.2021.02.014
  • Cyr, M. P., Dumoulin, C., Bessette, P., Pina, A., Gotlieb, W. H., Lapointe-Milot, K., Mayrand, M. H., & Morin, M. (2020). Feasibility, acceptability and effects of multimodal pelvic floor physical therapy for gynecological cancer survivors suffering from painful sexual intercourse: A multicenter prospective interventional study. Gynecologic oncology, 159(3), 778–784. https://doi.org/10.1016/j.ygyno.2020.09.001
  • Levin, G., Matanes, E., Yasmeen, A., Meyer, R., Brodeur, M. N., Salvador, S., Lau, S., Saragovi, H. U., & Gotlieb, W. (2025). GD2 and GD3 gangliosides as prognostic biomarkers in high grade serous ovarian cancer. Journal of gynecology obstetrics and human reproduction, 54(1), 102860. https://doi.org/10.1016/j.jogoh.2024.102860
  • Philip, C. A., Laskov, I., Beauchamp, M. C., Marques, M., Amin, O., Bitharas, J., Kessous, R., Kogan, L., Baloch, T., Gotlieb, W. H., & Yasmeen, A. (2017). Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors. BMC cancer, 17(1), 638. https://doi.org/10.1186/s12885-017-3639-0
  • Kessous, R., Octeau, D., Klein, K., Tonin, P. N., Greenwood, C. M. T., Pelmus, M., Laskov, I., Kogan, L., Salvador, S., Lau, S., Yasmeen, A., & Gotlieb, W. H. (2018). Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer. Gynecologic oncology, 148(3), 553–558. https://doi.org/10.1016/j.ygyno.2018.01.017
  • Tota, J. E., Bentley, J., Blake, J., Coutlée, F., Duggan, M. A., Ferenczy, A., Franco, E. L., Fung-Kee-Fung, M., Gotlieb, W., Mayrand, M. H., McLachlin, M., Murphy, J., Ogilvie, G., & Ratnam, S. (2017). Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening. Preventive medicine, 98, 15–20. https://doi.org/10.1016/j.ypmed.2016.11.030
  • Blank, N., Laskov, I., Kessous, R., Kogan, L., Lau, S., Sebag, I. A., Gotlieb, W. H., & Rudski, L. (2017). Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin. Cancer chemotherapy and pharmacology, 80(4), 737–743. https://doi.org/10.1007/s00280-017-3412-8
  • Zakhari, A., Czuzoj-Shulman, N., Spence, A. R., Gotlieb, W. H., & Abenhaim, H. A. (2016). Hysterectomy for Uterine Cancer in the Elderly: A Comparison Between Laparoscopic and Robot-Assisted Techniques. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 26(7), 1222–1227. https://doi.org/10.1097/IGC.0000000000000764
  • Matanes, E., Gupta, V., Kogan, L., Racicot, J., Salvador, S., Gotlieb, W. H., & Lau, S. (2021). Surgical Technique for Sentinel Lymph Node Sampling in Presumed Early-stage Ovarian Cancer. Journal of minimally invasive gynecology, 28(8), 1446. https://doi.org/10.1016/j.jmig.2020.12.030
  • El-Zein, M., Bouten, S., Louvanto, K., Gilbert, L., Gotlieb, W., Hemmings, R., Behr, M. A., Franco, E. L., & CASSIS Study Group (2018). Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study. Gynecologic oncology, 149(3), 491–497. https://doi.org/10.1016/j.ygyno.2018.04.004
  • Matanes, E., Eisenberg, N., Amajoud, Z., Gupta, V., Yasmeen, A., Ismail, S., Racovitan, F., Raban, O., Lau, S., Salvador, S., Gotlieb, W. H., & Kogan, L. (2021). Sentinel Lymph Node Sampling as an Alternative to Lymphadenectomy in Patients With Endometrial Cancer and Obesity. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 43(10), 1136–1144.e1. https://doi.org/10.1016/j.jogc.2021.04.014
  • Matanes, E., López-Ozuna, V. M., Octeau, D., Baloch, T., Racovitan, F., Dhillon, A. K., Kessous, R., Raban, O., Kogan, L., Salvador, S., Lau, S., Gotlieb, W. H., & Yasmeen, A. (2021). Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents. Frontiers in oncology, 11, 745981. https://doi.org/10.3389/fonc.2021.745981
  • Laskov, I., Abou-Nader, P., Amin, O., Philip, C. A., Beauchamp, M. C., Yasmeen, A., & Gotlieb, W. H. (2016). Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 26(7), 1213–1221. https://doi.org/10.1097/IGC.0000000000000761
  • Kessous, R., Wissing, M. D., Piedimonte, S., Abitbol, J., Kogan, L., Laskov, I., Yasmeen, A., Salvador, S., Lau, S., & Gotlieb, W. H. (2020). CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer. Acta obstetricia et gynecologica Scandinavica, 99(7), 933–940. https://doi.org/10.1111/aogs.13814
  • Tzur, Y., Brezinov, Y., Bar-Noy, T., Yasmeen, A., Brodeur, M. N., Salvador, S., Gotlieb, W. H., & Lau, S. (2026). Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery. Current oncology (Toronto, Ont.), 33(2), 71. https://doi.org/10.3390/curroncol33020071
  • Taylor, S., Scalia, P., Meyer, R., Salvador, S., Lau, S., Gotlieb, W., & Levin, G. (2026). Single-Agent Gemcitabine in Heavily Pretreated Ovarian Cancer: Experience from a Canadian Tertiary Centre. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 48(4), 103237. https://doi.org/10.1016/j.jogc.2026.103237
  • Nguyen, D. B., Czuzoj-Shulman, N., Alshaya, A., Gotlieb, W. H., & Abenhaim, H. A. (2019). The effect of rural vs. urban setting on the management and outcomes of surgery for endometrial cancer. Journal of gynecology obstetrics and human reproduction, 48(9), 745–749. https://doi.org/10.1016/j.jogoh.2019.06.001
  • Levin, G., Brodeur, M. N., Meyer, R., Bliman, Y. T., Salvador, S., Lau, S., & Gotlieb, W. (2026). Minimally invasive surgery versus open surgery for uterine sarcomas – a retrospective study. Journal of gynecology obstetrics and human reproduction, 55(5), 103147. https://doi.org/10.1016/j.jogoh.2026.103147
  • Uppal, S., Gehrig, P. A., Peng, K., Bixel, K. L., Matsuo, K., Vetter, M. H., Davidson, B. A., Cisa, M. P., Lees, B. F., Brunette, L. L., Tucker, K., Stuart Staley, A., Gotlieb, W. H., Holloway, R. W., Essel, K. G., Holman, L. L., Goldfeld, E., Olawaiye, A., & Rose, S. L. (2020). Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 38(10), 1030–1040. https://doi.org/10.1200/JCO.19.03012
  • Taylor, S., Scalia, P., Meyer, R., Nourmoussavi Brodeur, M., Salvador, S., Lau, S., Gotlieb, W., & Levin, G. (2025). Association of body mass index with pathologic agreement of preoperative and postoperative tumor grade in endometrial cancer. Archives of gynecology and obstetrics, 311(2), 459–465. https://doi.org/10.1007/s00404-024-07829-z
  • Piedimonte, S., Czuzoj-Shulman, N., Gotlieb, W., & Abenhaim, H. A. (2019). Robotic Radical Hysterectomy for Cervical Cancer: A Population-Based Study of Adoption and Immediate Postoperative Outcomes in the United States. Journal of minimally invasive gynecology, 26(3), 551–557. https://doi.org/10.1016/j.jmig.2018.08.012
  • Feigenberg, T., Cormier, B., Gotlieb, W. H., Jegatheeswaran, K., Helpman, L., Kim, S. R., Lau, S., May, T., Saab, D., Plante, M., Renaud, M. C., Samouelian, V., Shamiya, S., Vicus, D., Wright, K., & Kwon, J. S. (2021). Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP). Gynecologic oncology, 162(3), 606–612. https://doi.org/10.1016/j.ygyno.2021.06.013
  • Jegatheeswaran, K., Cormier, B., Dube, S., Gotlieb, W. H., Helpman, L., Kwon, J. S., Lau, S., Mah, S., May, T., Saab, D., McNeill, M., Plante, M., Renaud, M. C., Shamiya, S., Vicus, D., Parra-Herran, C., & Feigenberg, T. (2020). Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP). Gynecologic oncology, 159(1), 52–57. https://doi.org/10.1016/j.ygyno.2020.06.510
  • Octeau, D., Abitbol, J., Amajoud, Z., Laskov, I., Ferenczy, A., Pelmus, M., Eisenberg, N., Kessous, R., Matanes, E., Lau, S., Yasmeen, A., Lopez-Ozuna, V., Salvador, S., Gotlieb, W. H., & Kogan, L. (2019). Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy. Gynecologic oncology reports, 30, 100521. https://doi.org/10.1016/j.gore.2019.100521
  • Greenwald, Z. R., Huang, L. N., Wissing, M. D., Franco, E. L., & Gotlieb, W. H. (2017). Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?. Cancer, 123(9), 1545–1554. https://doi.org/10.1002/cncr.30529
  • Sun, P., Wu, Q., Ruan, G., Zheng, X., Song, Y., Zhun, J., Wu, L., & Gotlieb, W. H. (2016). Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia. Oncology letters, 12(5), 3135–3142. https://doi.org/10.3892/ol.2016.5074
  • Levin, G., Ramirez, P. T., Wright, J. D., Slomovitz, B. M., Gotlieb, W. H., Siedhoff, M. T., Wright, K. N., & Meyer, R. (2025). Examining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial Neoplasia. Cancers, 17(8), 1257. https://doi.org/10.3390/cancers17081257
  • Bar-Noy, T., Tzur, Y., Brezinov, Y., Matanes, E., Lozano-Franco, R., Salvador, S., Brodeur, M. N., Gotlieb, W., & Lau, S. (2025). Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Endometrial Intraepithelial Neoplasia Undergoing Robotic Surgery: A Retrospective Cohort Study. Cancers, 17(18), 2972. https://doi.org/10.3390/cancers17182972
  • Ahmed, S., Maheu, C., Gotlieb, W., Batist, G., & Loiselle, C. G. (2025). Feasibility, Acceptability, and Potential Effects of a Digital Oral Anticancer Agent Intervention: Protocol for a Pilot Randomized Controlled Trial. JMIR research protocols, 14, e55475. https://doi.org/10.2196/55475
  • Malagón, T., Kulasingam, S., Mayrand, M. H., Ogilvie, G., Smith, L., Bouchard, C., Gotlieb, W., & Franco, E. L. (2018). Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study. The Lancet. Oncology, 19(12), 1569–1578. https://doi.org/10.1016/S1470-2045(18)30536-9
  • Tota, J. E., Bentley, J., Blake, J., Coutlée, F., Duggan, M. A., Ferenczy, A., Franco, E. L., Fung-Kee-Fung, M., Gotlieb, W., Mayrand, M. H., McLachlin, M., Murphy, J., Ogilvie, G., & Ratnam, S. (2017). Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm. Preventive medicine, 98, 5–14. https://doi.org/10.1016/j.ypmed.2016.11.029
  • Mitric, C., How, B., Matanes, E., Amajoud, Z., Zaaroura, H., Nguyen, H. H., Tatar, A., Salvador, S., Gotlieb, W. H., & Lau, S. (2021). Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: A pilot project. Gynecologic oncology reports, 37, 100842. https://doi.org/10.1016/j.gore.2021.100842
  • Piedimonte, S., Kessous, R., Laskov, I., Abitbol, J., Kogan, L., Yasmeen, A., Salvador, S., Lau, S., & Gotlieb, W. H. (2020). Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 42(11), 1339–1345. https://doi.org/10.1016/j.jogc.2020.04.014
  • Henry, M., Cohen, S. R., Heyland, D. K., Platt, R., Zhang, X., Gotlieb, W., Lau, S., Vasilevsky, C. A., Hier, M., Sadeghi, N., Sultanem, K., Batist, G., Costa, M., Bolster-Foucault, C., Wang, C. S., & Agulnik, J. (2026). Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial. Psycho-oncology, 35(3), e70421. https://doi.org/10.1002/pon.70421
  • Kogan, L., Octeau, D., Amajoud, Z., Abitbol, J., Laskov, I., Ferenczy, A., Pelmus, M., Eisenberg, N., Kessous, R., Lau, S., Yasmeen, A., Gotlieb, W. H., & Salvador, S. (2018). Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors. Gynecologic oncology reports, 24, 43–47. https://doi.org/10.1016/j.gore.2018.03.004
  • Brodeur, M. N., Dopeso, H., Zhu, Y., Longhini, A. L. F., Gazzo, A., Sun, S., Koche, R. P., Qu, R., Rosenberg, L., Hamard, P. J., Bykov, Y., Green, H., Gusain, L., Chiappinelli, K. B., Ozsoy, M. A., Chui, M. H., Basili, T., Gardner, R., Walderich, S., DeStanchina, E., … Zamarin, D. (2024). Interferon response and epigenetic modulation by SMARCA4mutations drive ovarian tumor immunogenicity. Science advances, 10(49), eadk4851. https://doi.org/10.1126/sciadv.adk4851
  • Moufarrij, S., Dopeso, H., Brown, D. N., Green, H., Gill, K., Tengelin, J., Brodeur, M. N., Zammarrelli, W. A., 3rd, Varice, N., Wu, M., Jungbluth, A., Zhu, Y., Chen, X., Da Cruz Paula, A., Basili, T., de Stanchina, E., Abu-Rustum, N. R., Aghajanian, C., Ellenson, L. H., Chui, M. H., … Weigelt, B. (2025). TROP2 expression and therapeutic targeting in uterine carcinosarcoma. Gynecologic oncology, 197, 129–138. https://doi.org/10.1016/j.ygyno.2025.04.590
  • Praiss, A. M., Moukarzel, L. A., Zhu, Y., Longhini, A. L. F., Derakhshan, F., Hoang, T., Pesci, G., Green, H., Ozsoy, M. A., Hanlon, E., Kahn, R., Brodeur, M. N., Sia, T., Abu-Rustum, N. R., Gardner, G., Roche, K. L., Sonoda, Y., Zivanovic, O., Chi, D. S., Merghoub, T., … Zamarin, D. (2025). Evolution of tumor stress response during cytoreductive surgery for ovarian cancer. iScience, 28(5), 112317. https://doi.org/10.1016/j.isci.2025.112317
  • Brodeur, M. N., Selenica, P., Ma, W., Moufarrij, S., Dagher, C., Basili, T., Abu-Rustum, N. R., Aghajanian, C., Zhou, Q., Iasonos, A., Ellenson, L. H., Weigelt, B., & Chui, M. H. (2024). ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype. Molecular oncology, 18(10), 2356–2368. https://doi.org/10.1002/1878-0261.13698
  • Patra, B., Lateef, M. A., Brodeur, M. N., Fleury, H., Carmona, E., Péant, B., Provencher, D., Mes-Masson, A. M., & Gervais, T. (2020). Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems. PloS one, 15(12), e0244549. https://doi.org/10.1371/journal.pone.0244549
  • Kim, D. K., Mostafa, M., Aizenberg, Y., Brodeur, M. N., Carey, M. S., Ferguson, S. E., Hopkins, L., Kong, I., Kwon, J. S., Lau, S., Pepin, D., Willows, K., Wood, C., & McTaggart-Cowan, H. (2026). Applying the health belief model to explore healthcare provider and patient perspectives on homologous recombination deficiency testing in cancer: A narrative review. Cancer treatment and research communications, 47, 101238. https://doi.org/10.1016/j.ctarc.2026.101238
  • Brodeur, M. N., Simeone, K., Leclerc-Deslauniers, K., Fleury, H., Carmona, E., Provencher, D. M., & Mes-Masson, A. M. (2021). Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models. Scientific reports, 11(1), 18183. https://doi.org/10.1038/s41598-021-97434-w
  • Brodeur, M. N., Samouëlian, V., Dabi, Y., Cormier, B., Beauchemin, M. C., & Barkati, M. (2021). Neoadjuvant radiotherapy and brachytherapy in endometrial cancer with gross cervical involvement: a CHIRENDO research group study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(1), 78–84. https://doi.org/10.1136/ijgc-2020-001797
  • Brodeur, M. N., Dejean, R., Beauchemin, M. C., Samouëlian, V., Cormier, B., Bacha, O. M., Warkus, T., & Barkati, M. (2021). Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer. Gynecologic oncology, 162(2), 277–283. https://doi.org/10.1016/j.ygyno.2021.05.023
  • Ma, K., Tessier-Cloutier, B., Altman, A. D., Carey, M. S., Ethier, J. L., Lau, S., Lee, C. H., Hopkins, L., Kieser, K., Kumar, A., Leung, S. O. A., Nguyen, J. M. V., MacKay, H., McGee, J., Salman, L., Salvador, S., Sluce, C., Tatar, L., Tone, A. A., Tinker, A., … Brodeur, M. N. (2026). Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer. Current oncology (Toronto, Ont.), 33(6), 330. https://doi.org/10.3390/curroncol33060330
  • Vergote, I., Copeland, L. J., Van Gorp, T., Laenen, A., Scambia, G., Thaker, P. H., Cibula, D., Colombo, N., Lea, J., Gonzalez-Martin, A., Korach, J., Sehouli, J., Monk, B. J., Heinzelmann-Schwarz, V., Berger, R., Buscema, J., Lau, S., Mądry, R., Denys, H., Pepin, J. T., … ENGOT-ov50/GOG-3029/INNOVATE-3 Study Investigators (2025). Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study. European journal of cancer (Oxford, England : 1990), 219, 115306. https://doi.org/10.1016/j.ejca.2025.115306
  • Lau, S., Abdul Aziz, Y. F., & Ng, K. H. (2017). Mammographic compression in Asian women. PloS one, 12(4), e0175781. https://doi.org/10.1371/journal.pone.0175781
  • Jamieson, A., Huvila, J., Leung, S., Chiu, D., Thompson, E. F., Lum, A., Kinloch, M., Helpman, L., Salvador, S., Vicus, D., Kean, S., Samouelian, V., Grondin, K., Irving, J., Offman, S., Parra-Herran, C., Lau, S., Scott, S., Plante, M., McConechy, M. K., … McAlpine, J. N. (2023). Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. Gynecologic oncology, 170, 282–289. https://doi.org/10.1016/j.ygyno.2023.01.025
  • Bernard, L., Pond, G. R., Elit, L., Vicus, D., Piedimonte, S., Nelson, G., Aubrey, C., Plante, M., Teo-Fortin, L. A., Lau, S., Kwon, J., Kim, S. R., Altman, A. D., Mercier, N. B., Willows, K., Sadeq, N., Feigenberg, T., Sabourin, J., Samouelian, V., Helpman, L., … Canadian Collaborative Cervical Cancer group (4C) (2024). Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 50(10), 108518. https://doi.org/10.1016/j.ejso.2024.108518
  • Piedimonte, S., Helpman, L., Pond, G., Nelson, G., Kwon, J., Altman, A., Feigenberg, T., Elit, L., Lau, S., Sabourin, J., Samouelian, V., Willows, K., Aubrey, C., Jang, J. H., Teo-Fortin, L. A., Cockburn, N., Saunders, N. B., Shamiya, S., Vicus, D., Plante, M., … 4C: Canadian Cervical Cancer Collaborative (2023). Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study. Gynecologic oncology, 174, 21–27. https://doi.org/10.1016/j.ygyno.2023.03.005
  • Aubrey, C., Pond, G. R., Helpman, L., Vicus, D., Elit, L., Plante, M., Lau, S., Kwon, J. S., Altman, A. D., Willows, K., Feigenberg, T., Sabourin, J., Samouelian, V., Bernard, L., Cockburn, N., Saunders, N. B., Piedimonte, S., Teo-Fortin, L. A., Kim, S. R., Sadeq, N., … Nelson, G. (2023). Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study. Current oncology (Toronto, Ont.), 30(2), 1977–1985. https://doi.org/10.3390/curroncol30020153
  • Kosa, S. D., Ferguson, S. E., Panzarella, T., Lau, S., Abitbol, J., Samouëlian, V., Giede, C., Steed, H., Renkosinski, B., Gien, L. T., & Bernardini, M. Q. (2022). A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher. Journal of surgical oncology, 125(4), 747–753. https://doi.org/10.1002/jso.26769
  • Piedimonte, S., Pond, G. R., Plante, M., Nelson, G., Kwon, J., Altman, A., Feigenberg, T., Elit, L., Lau, S., Sabourin, J., Willows, K., Aubrey, C., Jang, J. H., Teo-Fortin, L. A., Cockburn, N., Saunders, N. B., Shamiya, S., Helpman, L., Vicus, D., & 4C: Canadian Cervical Cancer Collaborative (2022). Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study. Gynecologic oncology, 166(2), 230–235. https://doi.org/10.1016/j.ygyno.2022.05.011
  • Scalia, P., Levin, G., & Lau, S. (2024). Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor. European journal of obstetrics, gynecology, and reproductive biology, 300, 372–373. https://doi.org/10.1016/j.ejogrb.2024.07.066
  • Piedimonte, S., Leung, A., Zakhari, A., Giordano, C., Tellier, P. P., & Lau, S. (2018). Impact of an HPV Education and Vaccination Campaign among Canadian University Students. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 40(4), 440–446. https://doi.org/10.1016/j.jogc.2017.07.028
  • Matulonis, U. A., Walder, L., Nøttrup, T. J., Bessette, P., Mahner, S., Gil-Martin, M., Kalbacher, E., Ledermann, J. A., Wenham, R. M., Woie, K., Lau, S., Marmé, F., Casado Herraez, A., Hardy-Bessard, A. C., Banerjee, S., Lindahl, G., Benigno, B., Buscema, J., Travers, K., Guy, H., … Mirza, M. R. (2019). Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(34), 3183–3191. https://doi.org/10.1200/JCO.19.00917
  • Lau, S., Ng, K. H., & Abdul Aziz, Y. F. (2016). Volumetric breast density measurement: sensitivity analysis of a relative physics approach. The British journal of radiology, 89(1066), 20160258. https://doi.org/10.1259/bjr.20160258
  • Ferguson, S. E., Panzarella, T., Lau, S., Gien, L. T., Samouëlian, V., Giede, C., Steed, H., Le, T., Renkosinski, B., & Bernardini, M. Q. (2018). Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer. Gynecologic oncology, 149(3), 476–483. https://doi.org/10.1016/j.ygyno.2018.04.558
  • Ma, K., Tessier-Cloutier, B., Altman, A. D., Carey, M. S., Ethier, J. L., Lau, S., Lee, C. H., Hopkins, L., Kieser, K., Kumar, A., Leung, S. O. A., Nguyen, J. M. V., MacKay, H., McGee, J., Salman, L., Salvador, S., Sluce, C., Tatar, L., Tone, A. A., Tinker, A., … Brodeur, M. N. (2026). Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian Cancer. Current oncology (Toronto, Ont.), 33(6), 330. https://doi.org/10.3390/curroncol33060330
  • Tatar, O., Zhu, P., Salvador, S., Lau, S., Ruel-Laliberté, J., Perez, S., McBride, E., & Rosberger, Z. (2026). Transitioning from Cytology to HPV Test-Based Primary Cervical Screening in Canada: A Population-Based Survey of Women’s Screening and Information Preferences. Current oncology (Toronto, Ont.), 33(2), 95. https://doi.org/10.3390/curroncol33020095
  • Wang, X. S., Pond, G. R., Piedimonte, S., Nelson, G., Aubrey, C., Plante, M., Lau, S., Kwon, J., Chai, J., Altman, A. D., Willows, K., Feigenberg, T., Sabourin, J., Samouelian, V., Vicus, D., Helpman, L., & Canadian Cervical Cancer Collaborative (4C) Group (2026). Pre-operative positron emission tomography scan is associated with lower rates of adjuvant treatment in surgically treated patients with cervical cancer: a 4C Working Group study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 36(6), 104695. https://doi.org/10.1016/j.ijgc.2026.104695
  • Salvador, S., Scott, S., Glanc, P., Eiriksson, L., Jang, J. H., Sebastianelli, A., & Dean, E. (2020). Guideline No. 403: Initial Investigation and Management of Adnexal Masses. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 42(8), 1021–1029.e3. https://doi.org/10.1016/j.jogc.2019.08.044
  • Salvador, S., Scott, S., Francis, J. A., Agrawal, A., & Giede, C. (2017). No344-Salpingectomie opportuniste et autres méthodes pour réduire le risque de cancer de l’ovaire, de la trompe de Fallope et du péritoine dans la population générale. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 39(6), 494–508. https://doi.org/10.1016/j.jogc.2017.03.121
  • Jamieson, A., Huvila, J., Leung, S., Chiu, D., Thompson, E. F., Lum, A., Kinloch, M., Helpman, L., Salvador, S., Vicus, D., Kean, S., Samouelian, V., Grondin, K., Irving, J., Offman, S., Parra-Herran, C., Lau, S., Scott, S., Plante, M., McConechy, M. K., … McAlpine, J. N. (2023). Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. Gynecologic oncology, 170, 282–289. https://doi.org/10.1016/j.ygyno.2023.01.025
  • Zigras, T., Mayrand, M. H., Bouchard, C., Salvador, S., Eiriksson, L., Almadin, C., Kean, S., Dean, E., Malhotra, U., Todd, N., Fontaine, D., & Bentley, J. (2023). Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations. Current oncology (Toronto, Ont.), 30(6), 5652–5679. https://doi.org/10.3390/curroncol30060425
  • Auclair, M. H., Yong, P. J., Salvador, S., Thurston, J., Colgan, T. T. J., & Sebastianelli, A. (2019). Guideline No. 390-Classification and Management of Endometrial Hyperplasia. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 41(12), 1789–1800. https://doi.org/10.1016/j.jogc.2019.03.025
  • Eiriksson, L., Dean, E., Sebastianelli, A., Salvador, S., Comeau, R., Jang, J. H., Bouchard-Fortier, G., Osborne, R., & Sauthier, P. (2021). Guideline No. 408: Management of Gestational Trophoblastic Diseases. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 43(1), 91–105.e1. https://doi.org/10.1016/j.jogc.2020.03.001
  • Salvador, S., & An Advisory Committee of Federal and Provincial Experts in Support of Reducing Cervical Cancer Incidence and Advancing Equitable Healthcare for All (2025). HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention. Current oncology (Toronto, Ont.), 32(11), 594. https://doi.org/10.3390/curroncol32110594
  • Eiriksson, L., Dean, E., Sebastianelli, A., Salvador, S., Comeau, R., Jang, J. H., Bouchard-Fortier, G., Osborne, R., & Sauthier, P. (2021). Directive clinique no408 : Prise en charge des maladies gestationnelles trophoblastiques. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 43(1), 106–123.e1. https://doi.org/10.1016/j.jogc.2020.10.008
  • Francis, J. A., Eiriksson, L., Dean, E., Sebastianelli, A., Bahoric, B., & Salvador, S. (2019). No. 370-Management of Squamous Cell Cancer of the Vulva. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 41(1), 89–101. https://doi.org/10.1016/j.jogc.2018.07.004
  • Auclair, M. H., Yong, P. J., Salvador, S., Thurston, J., Colgan, T. T. J., & Sebastianelli, A. (2019). Directive clinique N° 392-Classification et prise en charge de l’hyperplasie de l’endomètre. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 41(12), 1801–1813. https://doi.org/10.1016/j.jogc.2019.07.012
  • Lebeau, J., Leung, J., Goettke, K., Cherniak, V., Alghamdi, T., Salvador, S., & Levin, G. (2024). A rare case report of bullous pemphigoid caused by paclitaxel treatment for endometrial cancer. European journal of obstetrics, gynecology, and reproductive biology, 300, 374–375. https://doi.org/10.1016/j.ejogrb.2024.07.067
  • Chappus-McCendie, H., Salvador, S., & Levin, G. (2025). Aspergillus-superinfected pulmonary metastases following treatment of recurrent endometrial cancer with immune checkpoint inhibitor. Archives of gynecology and obstetrics, 311(3), 861–862. https://doi.org/10.1007/s00404-024-07771-0
  • Salvador, S., Scott, S., Francis, J. A., Agrawal, A., & Giede, C. (2017). No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 39(6), 480–493. https://doi.org/10.1016/j.jogc.2016.12.005
  • Salvador, S., Scott, S., Francis, J. A., Agrawal, A., & Giede, C. (2018). Guidelines About Opportunistic Salpingectomy, IVF, and the Practical Side – In Response. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 40(1), 15–16. https://doi.org/10.1016/j.jogc.2017.08.001
  • Francis, J. A., Eiriksson, L., Dean, E., Sebastianelli, A., Bahoric, B., & Salvador, S. (2019). No370 – Prise en charge du cancer spinocellulaire de la vulve. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC, 41(1), 102–115. https://doi.org/10.1016/j.jogc.2018.11.016
  • Meyer, R., Lau, S., Salvador, S., Nasseri, Y., Barnajian, M., & Levin, G. (2026). Risk Factors for Readmission Following Minimally Invasive Hysterectomy for Benign Indications in the United States-Outpatient and Inpatient Setting. BJOG : an international journal of obstetrics and gynaecology, 133(5), 1093–1095. https://doi.org/10.1111/1471-0528.70123

Collaborations

Dr. Wilson Miller, Lady Davis Institute, Montreal

Dr. Sonia del Rincon, Lady Davis Institute, Montreal

Dr. Carolyn Baglole, RI-MUHC, McGill University, Montreal

Dr. Jun Ding, RI-MUHC, McGill University, Montreal

Dr. Susan Gaskin, Department of Chemical Engineering, McGill University, Montreal

Dr. Bernard Robaire, Department of Pharmacology McGill University, Montreal

Dr. Brandon Pearson, Columbia University, New York

Dr. John Wise, University of Louisville, Kentucky

News/Milestones

Dr. Wilson Miller, Lady Davis Institute, Montreal

Dr. Sonia del Rincon, Lady Davis Institute, Montreal

Dr. Carolyn Baglole, RI-MUHC, McGill University, Montreal

Dr. Jun Ding, RI-MUHC, McGill University, Montreal

Dr. Susan Gaskin, Dep’t of Chemical Engineering, McGill University, Montreal

Dr. Bernard Robaire, Dep’t of Pharmacology McGill University, Montreal

Dr. Brandon Pearson, Columbia University, New York

Dr. John Wise, University of Louisville, Kentucky

Lorem ipsum dolor sit amet consectetur adipisicing elit. Maxime mollitia, molestiae quas vel sint commodi repudiandae consequuntur voluptatum laborum numquam blanditiis harum quisquam eius sed odit fugiat iusto fuga praesentium optio, eaque rerum! Provident similique accusantium nemo autem. Veritatis obcaecati tenetur iure eius earum ut molestias architecto voluptate aliquam nihil, eveniet aliquid culpa officia aut! Impedit sit sunt quaerat, odit, tenetur error, harum nesciunt ipsum debitis quas aliquid. Reprehenderit, quia. Quo neque error repudiandae fuga? Ipsa laudantium molestias eos sapiente officiis modi at sunt excepturi expedita sint? Sed quibusdam recusandae alias error harum maxime adipisci amet laborum. Perspiciatis minima nesciunt dolorem! Officiis iure rerum voluptates a cumque velit quibusdam sed amet tempora. Sit laborum ab, eius fugit doloribus tenetur fugiat, temporibus enim commodi iusto libero magni deleniti quod quam consequuntur! 

  1. How iMALDI can improve clinical diagnostics. Popp, R., Basik, M., Spatz, A., Batist, G., Zahedi, R.P., Borchers, C.H., 2018. Analyst Clin. Chem. 64, 1271–1272. 143, 2197–2203.
  2. Immuno-MALDI-TOF-MS in the Clinic. Zahedi, R.P., Parker, C.E., Borchers, C.H., 2018.

Prix et récompenses

Walter Gotlieb :

  • 2023 Presidential Medal Award – La Société d’oncologie gynécologique du Canada (GOC)
  • 2016-2018 – Président de la Société d’oncologie gynécologique du Canada

Melica Brodeur :

  • 2022 Mentored Investigator Award – Alliance de recherche sur le cancer de l’ovaire (USA)
  • 2022 – American Association for Cancer Research (AACR) – Scholar-in-Training award
  • 2025 – Fonds de recherche du Québec – Chercheuse-boursière clinicienne – Junior 

Shannon Salvador :

  • 2024-2026 – Présidente de la Société d’oncologie gynécologique du Canada

Susie Lau :

  • 2025 – FRQ (Oncopole) – Réseau de recherche sur le cancer – Axe de recherche translationnelle et de banque de tissus et de données en cancers solides (BTD)
  • 2018 – Prix de l’éducateur Carl Nimrod, Société des obstétriciens et gynécologues du Canada (SOGC), Toronto, Ontario
  • 2018 – Minogue Medical recognition award for 500th da Vinci surgical procedure

Nikola Kukolj:

  • Undergraduate Student Research Awards – NSERC, 2023

Links

Titre

Lorem ipsum dolor sit amet consectetur adipisicing elit. Maxime mollitia, molestiae quas vel sint commodi repudiandae consequuntur voluptatum laborum numquam blanditiis harum quisquam eius sed odit fugiat iusto fuga praesentium optio, eaque rerum! Provident similique accusantium nemo autem. Veritatis obcaecati tenetur iure eius earum ut molestias architecto voluptate aliquam nihil, eveniet aliquid culpa officia aut! Impedit sit sunt quaerat, odit, tenetur error, harum nesciunt ipsum debitis quas aliquid. Reprehenderit, quia.

Titre

Events

Dr. Wilson Miller, Lady Davis Institute, Montreal

Dr. Sonia del Rincon, Lady Davis Institute, Montreal

Dr. Carolyn Baglole, RI-MUHC, McGill University, Montreal

Dr. Jun Ding, RI-MUHC, McGill University, Montreal

Dr. Susan Gaskin, Dep’t of Chemical Engineering, McGill University, Montreal

Dr. Bernard Robaire, Dep’t of Pharmacology McGill University, Montreal

Dr. Brandon Pearson, Columbia University, New York

Dr. John Wise, University of Louisville, Kentucky

Lorem ipsum dolor sit amet consectetur adipisicing elit. Maxime mollitia, molestiae quas vel sint commodi repudiandae consequuntur voluptatum laborum numquam blanditiis harum quisquam eius sed odit fugiat iusto fuga praesentium optio, eaque rerum! Provident similique accusantium nemo autem. Veritatis obcaecati tenetur iure eius earum ut molestias architecto voluptate aliquam nihil, eveniet aliquid culpa officia aut! Impedit sit sunt quaerat, odit, tenetur error, harum nesciunt ipsum debitis quas aliquid. Reprehenderit, quia. Quo neque error repudiandae fuga? Ipsa laudantium molestias eos sapiente officiis modi at sunt excepturi expedita sint? Sed quibusdam recusandae alias error harum maxime adipisci amet laborum. Perspiciatis minima nesciunt dolorem! Officiis iure rerum voluptates a cumque velit quibusdam sed amet tempora. Sit laborum ab, eius fugit doloribus tenetur fugiat, temporibus enim commodi iusto libero magni deleniti quod quam consequuntur! 

  1. How iMALDI can improve clinical diagnostics. Popp, R., Basik, M., Spatz, A., Batist, G., Zahedi, R.P., Borchers, C.H., 2018. Analyst Clin. Chem. 64, 1271–1272. 143, 2197–2203.
  2. Immuno-MALDI-TOF-MS in the Clinic. Zahedi, R.P., Parker, C.E., Borchers, C.H., 2018.

Soutien

Nous sommes reconnaissants du soutien financier que nous recevons des organismes de financement et des donateurs privés. Avec votre soutien, nous serons capables de faire des découvertes cliniques significatives pour améliorer les soins aux patients.

Remerciements particuliers à :

Fonds de Recherche du Québec – Santé

Reseau de recherche sur le cancer

Société de recherche sur le cancer

Ovarian Cancer Research Alliance

Institut de recherche Terry Fox

Digital Health Alliance of Canada

Fondation Gloria Girls Gloria Shapiro

Fonds israélien de recherche sur le cancer

Fondation de l’HGJ

Fondation Azrieli

Fonds de la famille Levy

Reseau de recherche sur le cancer

Fonds Susan et Jonathan Wener

Fonds Visman de l’Université de Tel Aviv

Week-end pour vaincre les cancers féminins

Contact

Institut Lady Davis de recherches médicales, Centre hospitalier universitaire général juif

3755, Ch. Côte Ste-Catherine 
Montréal, Québec H3T 1E2

Ayse Nazli Zengin, MSc

Courriel :

nazli.zengin@ladydavis.ca

Reception:

(514) 340-8260

Office:

(514) 340-8222 ext. 22760

Lab:

(514) 340-8222 ext. 24257
LDI logo

Cookies et technologies similaires

Notre site web utilise des cookies et des technologies similaires pour améliorer votre expérience en ligne et comprendre comment vous utilisez notre site web. Les cookies sont de petits fichiers de texte stockés sur votre appareil lorsque vous visitez un site web. Ils sont largement utilisés pour que le site fonctionne correctement, pour analyser le comportement des utilisateurs et pour personnaliser votre expérience.

Types de cookies utilisés

Nous utilisons les types de cookies suivants sur notre site web :

  • Cookies essentiels : ces cookies sont nécessaires au fonctionnement de notre site web. Ils vous permettent de naviguer sur le site et d'utiliser ses fonctionnalités de base. Sans ces cookies, certaines parties de notre site web ne fonctionneront pas correctement.
  • Cookies de performance : ces cookies collectent des informations concernant la manière dont les visiteurs utilisent notre site web - par exemple, les pages qu'ils consultent le plus fréquemment. Ces données nous aident à améliorer la performance de notre site web et à comprendre les préférences des utilisateurs.
  • Cookies de fonctionnalité : ces cookies permettent au site web de mémoriser les choix que vous avez faits (comme votre nom d'utilisateur, votre langue ou votre région) et de fournir des fonctionnalités améliorées et plus personnalisées. Ils peuvent également être utilisés pour fournir des services que vous avez demandés tels que le visionnement d’une vidéo ou l’écriture d’un commentaire.
  • Cookies de publicité : ces cookies sont utilisés pour diffuser des publicités pertinentes pour vous et vos préférences. Ils sont également utilisés pour limiter le nombre de fois que vous voyez une publicité et pour mesurer l'efficacité des campagnes publicitaires.